严重免疫功能低下患者接受多疗程瑞德西韦治疗后，SARS-CoV-2 持续复制。
Persistent replication of SARS-CoV-2 in a severely immunocompromised patient treated with several courses of remdesivir.
机构信息
Barcelona Institute for Global Health (ISGlobal) Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Hematology Department, Hospital Clínic, Barcelona, Spain.
出版信息
Int J Infect Dis. 2021 Mar;104:379-381. doi: 10.1016/j.ijid.2020.12.050. Epub 2020 Dec 21.
Microbiological response of SARS-CoV-2 to remdesivir in immunocompromised patients has not been evaluated. We present the case of a severely immunocompromised patient with persistent replication of SARS-CoV-2, who required different courses of remdesivir. Short courses of remdesivir might be insufficient in immunocompromised patients due to prolonged viral clearance.
尚未评估瑞德西韦在免疫功能低下患者中对 SARS-CoV-2 的微生物学反应。我们报告了一例严重免疫功能低下的患者，其 SARS-CoV-2 持续复制，需要不同疗程的瑞德西韦。由于病毒清除时间延长，免疫功能低下患者可能需要较短疗程的瑞德西韦治疗。
Zotero 插件